# IN Ketamine Vs IN Midazolam and Fentanyl for Abscess I&D

> **NCT02635282** · PHASE4 · COMPLETED · sponsor: **University of Tennessee** · enrollment: 19 (actual)

## Conditions studied

- Abscess
- Pain

## Interventions

- **DRUG:** intranasal ketamine
- **DRUG:** intranasal fentanyl
- **DRUG:** intranasal midazolam

## Key facts

- **NCT ID:** NCT02635282
- **Lead sponsor:** University of Tennessee
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2017-03-23
- **Final completion:** 2017-03-23
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2017-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02635282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02635282, "IN Ketamine Vs IN Midazolam and Fentanyl for Abscess I&D". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02635282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*